Cipla, Fosun deals

Indian Shares May Open Higher as Traders Trim Fed Hike Bets

Indian equities are poised to rise amid fading U.S. rate hike fears, with Brent crude stabilizing near $96. Key industry updates include Cipla securing a biosimilar Keytruda license and potential Fosu